Until recently, the maturation of the 3′-end of tRNA precursors in Bacteria has been assumed to follow the E. coli paradigm, in which a cleavage event downstream of tRNAs is followed by exonucleolytic ...
SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological ...
RNA is having a moment. Several, actually. RNA vaccines—unproven in a clinical setting until last year—are leading the immunization charge against the COVID-19 pandemic. And the Nobel Prize-winning ...
SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results